NewEdge Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.74M | Buy |
97,412
+6,749
| +7% | +$259K | 0.02% | 683 |
|
|
2025
Q1 | $3.51M | Buy |
90,663
+7,148
| +9% | +$277K | 0.02% | 632 |
|
|
2024
Q4 | $2.82M | Buy |
83,515
+8,262
| +11% | +$279K | 0.02% | 683 |
|
|
2024
Q3 | $3.08M | Buy |
75,253
+5,205
| +7% | +$213K | 0.02% | 628 |
|
|
2024
Q2 | $2.7M | Buy |
70,048
+26,793
| +62% | +$1.03M | 0.02% | 642 |
|
|
2024
Q1 | $1.85M | Buy |
43,255
+1,911
| +5% | +$81.9K | 0.02% | 724 |
|
|
2023
Q4 | $1.56M | Buy |
41,344
+2,423
| +6% | +$91.3K | 0.01% | 755 |
|
|
2023
Q3 | $1.41M | Buy |
38,921
+13,302
| +52% | +$482K | 0.02% | 719 |
|
|
2023
Q2 | $913K | Buy |
25,619
+2,844
| +12% | +$101K | 0.01% | 909 |
|
|
2023
Q1 | $810K | Sell |
22,775
-526
| -2% | -$18.7K | 0.01% | 883 |
|
|
2022
Q4 | $324K | Buy |
+23,301
| New | +$324K | 0.01% | 968 |
|
|
2022
Q3 | – | Sell |
-17,786
| Closed | -$968K | – | 1579 |
|
|
2022
Q2 | $968K | Sell |
17,786
-2,332
| -12% | -$127K | 0.02% | 677 |
|
|
2022
Q1 | $1.1M | Buy |
20,118
+5,067
| +34% | +$276K | 0.02% | 609 |
|
|
2021
Q4 | $830K | Buy |
+15,051
| New | +$830K | 0.01% | 832 |
|
|
2020
Q3 | – | Sell |
-4,494
| Closed | -$229K | – | 945 |
|
|
2020
Q2 | $229K | Sell |
4,494
-7,445
| -62% | -$379K | 0.01% | 741 |
|
|
2020
Q1 | $565K | Buy |
11,939
+6,518
| +120% | +$308K | 0.03% | 426 |
|
|
2019
Q4 | $318K | Buy |
5,421
+52
| +1% | +$3.05K | 0.01% | 645 |
|
|
2019
Q3 | $286K | Buy |
5,369
+732
| +16% | +$39K | 0.01% | 648 |
|
|
2019
Q2 | $232K | Buy |
+4,637
| New | +$232K | 0.01% | 583 |
|
|
2018
Q4 | – | Sell |
-5,649
| Closed | -$284K | – | 662 |
|
|
2018
Q3 | $284K | Buy |
+5,649
| New | +$284K | 0.02% | 509 |
|
|
2017
Q3 | – | Sell |
-1,658
| Closed | -$87.5K | – | 668 |
|
|
2017
Q2 | $87.5K | Buy |
+1,658
| New | +$87.5K | 0.02% | 439 |
|